Skip to content

Aquestive Therapeutics, Inc.

AQST· NasdaqCore metricsCIK 1398733

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.14%
Market cap
$448.71M
125.69M shares
Filings
692
$7.56M
Q3 2026−22.6% FY25 yoy
-$16.50M
Q3 2026N/M FY25 yoy
-$14.47M
Q3 2026N/M FY25 yoy
-$32.14M
Q3 2026derivedN/M FY25 yoy
-$0.13
Q3 2026N/M FY25 yoy
$90.35M
Q3 2026+69.4% FY25 yoy
$448.71M
—
9.2×
—
-9.07%
—

Twelve months to Sep 30, 2026 · derived

Price

$3.5737.15%$2.11past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$44.55MFY 2025
$67.43M0FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$44,545,000reported
FY 20242024-12-31$57,561,000reported
FY 20232023-12-31$50,583,000reported
FY 20222022-12-31$47,680,000reported
FY 20212021-12-31$50,832,000reported
FY 20202020-12-31$45,849,000reported
FY 20192019-12-31$52,609,000reported
FY 20182018-12-31$67,430,000reported
FY 20172017-12-31$66,918,000reported

Segments

Revenue by Geography, FY2019 to FY2025FY2019United States · FY2019 · $48.29MEx-United States · FY2019 · $4.32MFY2020United States · FY2020 · $40.96MEx-United States · FY2020 · $4.89MFY2021United States · FY2021 · $42.86MEx-United States · FY2021 · $7.97MFY2022United States · FY2022 · $40.79MEx-United States · FY2022 · $6.89MFY2023United States · FY2023 · $37.10MEx-United States · FY2023 · $13.48MFY2024United States · FY2024 · $39.93MEx-United States · FY2024 · $17.63MFY2025United States · FY2025 · $29.60MEx-United States · FY2025 · $14.94M
LineFY2025ShareChange
United States$29.60M66%−25.9%
Ex-United States$14.94M34%−15.3%
Total$44.55M

From the 10-K filed Mar 4, 2026AQST

Pharmaceutical preparations

Aquestive Therapeutics, Inc. is the 132nd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Aquestive Therapeutics, Inc. · CIK 1398733 · Engraved from SEC EDGAR